ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,434Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 2094

$835K Total Retail Price of All Prescriptions

Rank: 157 out of 2094

462 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,992 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 436 391 1 1
OMEPRAZOLE 434 358 2 4
LEVOTHYROXINE SODIUM 385 357 3 3
AMLODIPINE BESYLATE 347 322 4 2
METOPROLOL TARTRATE 277 249 5 10
HYDROCHLOROTHIAZIDE 252 204 6 12
FUROSEMIDE 243 225 7 6
NAMENDA 208 208 8 32
FAMOTIDINE 207 190 9 34
DONEPEZIL HCL 202 202 10 20
NYSTATIN 200 159 11 167
METOPROLOL SUCCINATE 191 180 12 9
ATORVASTATIN CALCIUM 179 150 13 5
METFORMIN HCL 176 157 14 8
LIDODERM 168 144 15 59
WARFARIN SODIUM 165 157 16 11
POTASSIUM CHLORIDE 156 149 17 24
NOVOLOG 151 138 18 116
CITALOPRAM HBR 150 112 19 47
OXYCODONE-ACETAMINOPHEN 143 109 S2 20 40
ADVAIR DISKUS 139 118 21 36
RISPERIDONE 128 110 22 56
ENALAPRIL MALEATE 128 127 22 25
CLOPIDOGREL 110 109 24 22
LANTUS 106 92 25 66
LISINOPRIL 104 81 26 7
CARVEDILOL 101 99 27 19
LOSARTAN POTASSIUM 100 98 28 17
DIOVAN 96 96 29 13
LIDOCAINE 95 95 30 217
PRAVASTATIN SODIUM 92 92 31 18
ATENOLOL 92 92 31 21
TRAMADOL HCL 86 77 33 33
TAMSULOSIN HCL 86 83 33 29
GLIMEPIRIDE 85 68 35 31
PREDNISONE 85 83 35 54
PLAVIX 83 82 37 38
GABAPENTIN 83 68 37 23
MIRTAZAPINE 80 77 39 43
FLUTICASONE PROPIONATE 73 63 40 41
OXYBUTYNIN CHLORIDE ER 73 60 40 138
ZOLPIDEM TARTRATE 72 60 42 14
FENTANYL 72 66 S2 42 68
ESCITALOPRAM OXALATE 71 70 44 46
AZITHROMYCIN 71 62 44 27
TRAVATAN Z 69 66 46 189
PANTOPRAZOLE SODIUM 67 65 47 37
HYDROMORPHONE HCL 65 0 S2 48 225
SERTRALINE HCL 64 46 49 26
DIVALPROEX SODIUM 63 61 50 69
LEVOFLOXACIN 63 61 50 70
LACTULOSE 63 63 50 65
BUDESONIDE 60 60 53 228
ALENDRONATE SODIUM 60 59 53 30
CLONIDINE 59 59 55 261
RENVELA 58 58 56 263
NOVOLIN R 58 57 56 214
TRAZODONE HCL 57 45 58 72
DIGOXIN 56 56 59 51
IPRATROPIUM-ALBUTEROL 54 49 60 92
CRESTOR 53 51 61 15
NITROGLYCERIN PATCH 53 53 61 101
LIDOCAINE HCL 52 52 63 400
SINGULAIR 51 41 64 64
GLIPIZIDE 50 33 65 82
QUETIAPINE FUMARATE 50 46 65 71
CLONIDINE HCL 50 50 65 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.